Quick Answer
NANOVIRICIDES, INC. reported Stockholders Equity of $7.52 million for fiscal year 2025.
NANOVIRICIDES, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.52M | -34.4% |
| 2024 | $11.46M | -22.9% |
| 2023 | $14.87M | -35.6% |
| 2022 | $23.08M | -22.8% |
| 2021 | $29.91M | +37.5% |
| 2020 | $21.76M | +105.3% |
| 2019 | $10.60M | -40.0% |
| 2018 | $17.66M | -13.1% |
| 2017 | $20.32M | -11.8% |
| 2016 | $23.05M | -27.5% |
| 2015 | $31.79M | +36.0% |
| 2014 | $23.37M | +191.8% |
| 2013 | $8.01M | -42.2% |
| 2012 | $13.85M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $11.07M | +6.6% | +54.3% |
| September 30, 2025 | $7.17M | -29.0% | -4.6% |
| June 30, 2025 | $7.52M | -34.4% | -14.9% |
| March 31, 2025 | $8.83M | -17.1% | -15.0% |
| December 31, 2024 | $10.39M | -16.6% | +2.8% |
| September 30, 2024 | $10.11M | -22.1% | -11.8% |
| June 30, 2024 | $11.46M | -22.9% | +7.6% |
| March 31, 2024 | $10.65M | -41.6% | -14.5% |
- NANOVIRICIDES, INC. showed a decrease of -34.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, NANOVIRICIDES, INC.’s stockholders equity has declined by 45.7% (from $13.85 million to $7.52 million).
- The most recent figure is from NANOVIRICIDES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: